UBS Group’s NRX Pharmaceuticals NRXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$396K Buy
121,608
+121,503
+115,717% +$396K ﹤0.01% 5017
2025
Q1
$215 Sell
105
-45
-30% -$92 ﹤0.01% 8562
2024
Q4
$330 Buy
150
+112
+295% +$246 ﹤0.01% 8267
2024
Q3
$64 Sell
38
-1,049
-97% -$1.77K ﹤0.01% 7996
2024
Q2
$2.65K Sell
1,087
-570
-34% -$1.39K ﹤0.01% 7157
2024
Q1
$7.82K Sell
1,657
-3,027
-65% -$14.3K ﹤0.01% 6189
2023
Q4
$21.5K Buy
4,684
+4,563
+3,771% +$21K ﹤0.01% 5856
2023
Q3
$315 Sell
121
-155
-56% -$404 ﹤0.01% 7443
2023
Q2
$1.33K Sell
276
-1,585
-85% -$7.65K ﹤0.01% 6860
2023
Q1
$12.3K Buy
1,861
+1,822
+4,672% +$12K ﹤0.01% 6361
2022
Q4
$433 Buy
+39
New +$433 ﹤0.01% 8981
2022
Q3
Sell
-1,680
Closed -$10K 9523
2022
Q2
$10K Buy
1,680
+1,227
+271% +$7.3K ﹤0.01% 6940
2022
Q1
$11K Sell
453
-721
-61% -$17.5K ﹤0.01% 7254
2021
Q4
$56K Buy
+1,174
New +$56K ﹤0.01% 5705
2021
Q3
Sell
-839
Closed -$97K 8637
2021
Q2
$97K Buy
+839
New +$97K ﹤0.01% 4866
2021
Q1
Sell
-23
Closed -$6K 8125
2020
Q4
$6K Sell
23
-23
-50% -$6K ﹤0.01% 6736
2020
Q3
$5K Sell
46
-37
-45% -$4.02K ﹤0.01% 6433
2020
Q2
$9K Sell
83
-120
-59% -$13K ﹤0.01% 6230
2020
Q1
$22K Buy
203
+30
+17% +$3.25K ﹤0.01% 5534
2019
Q4
$18K Buy
173
+20
+13% +$2.08K ﹤0.01% 5879
2019
Q3
$16K Sell
153
-174
-53% -$18.2K ﹤0.01% 5913
2019
Q2
$34K Sell
327
-83
-20% -$8.63K ﹤0.01% 5369
2019
Q1
$42K Buy
+410
New +$42K ﹤0.01% 4872
2018
Q3
Sell
-130
Closed -$13K 7116
2018
Q2
$13K Hold
130
﹤0.01% 6069
2018
Q1
$13K Buy
+130
New +$13K ﹤0.01% 5835